Danaher Corp
Change company Symbol lookup
Select an option...
DHR Danaher Corp
VTSI VirTra Inc
ALHC Alignment Healthcare Inc
PRGS Progress Software Corp
PMD Psychemedics Corp
RPHM Reneo Pharmaceuticals Inc
DFSU Dimensional US Sustainability Core 1 ETF
UNH UnitedHealth Group Inc
GURE Gulf Resources Inc
TDCX TDCX Inc
Go

Health Care : Life Sciences Tools & Services | Large Cap Blend
Company profile

Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s segments include Biotechnology, which includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services; Life Sciences segment, which offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics segment that offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease, and Environmental & Applied Solutions segment, which offers products and services that help protect precious resources and keep global food and water supplies safe.

Closing Price
$252.04
Day's Change
2.24 (0.90%)
Bid
--
Ask
--
B/A Size
--
Day's High
252.75
Day's Low
249.66
Volume
(Above Average)
Volume:
2,754,736

10-day average volume:
2,325,278
2,754,736

Company Profile

Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s segments include Biotechnology, which includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services; Life Sciences segment, which offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics segment that offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease, and Environmental & Applied Solutions segment, which offers products and services that help protect precious resources and keep global food and water supplies safe.

Valuation Ratios

Price/Earnings (TTM)
26.08x
Price/Sales (TTM)
5.84x
Price/Book (MRQ)
3.79x
Price/Cash Flow (TTM)
19.71x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

March 2023
Current Month
3.5M
Previous Month
3.7M
Percent of Float
0.53%
Days to Cover
1.3796 Days

Share Information

DHR is in a share class of common stock
Float
648.2M
Shares Outstanding
729.1M
Institutions Holding Shares
2,861
78.48%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Steven M. RalesChmn.
  • Rainer M. BlairPres.
  • Mitchell P. Rales
  • Matthew R. McGrewCFO
  • Jennifer L. HoneycuttExec.VP

Address

  • 2200 Pennsylvania Ave Nw Ste 800W
  • Washington, DC 20037-1731
  • Phone: (202) 828-0850
  • Fax: (202) 828-0860
  • https://www.danaher.com/

Insider Trading

During the most recent quarter, 47K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.